Trending Posts

Lorem ipsum dolor sit amet, consectetur adipiscing elit
MedInvest 2025: How NeuroOne’s AI-Enabled Brain Stimulation and…

Key Highlights: 1. NeuroOne’s Vision: AI for Real-World Neurological DisordersNeuroOne will join MedInvest’s MedTech, AI & Digital Health…

ByByAnuja SinghJun 4, 2025
How CareCloud Is Applying AI to Transform Clinical…

Key Highlights CareCloud to Join Elite Healthcare IT Panel at Maxim ConferenceCareCloud, Inc. (Nasdaq: CCLD, CCLDO), a leading…

ByByAnuja SinghJun 4, 2025
How Insilico’s AI-Discovered Drug Achieved a Landmark Clinical…

Key Highlights:• Insilico Medicine’s AI-driven drug discovery platform Pharma.AI enabled rapid development of Rentosertib, a novel TNIK inhibitor…

ByByAnuja SinghJun 4, 2025
Can VUMC’s New AI Technologies Reshape Cancer Diagnostics…

Key Highlights AI-Powered MSI-SEER Revolutionizes Tumor ProfilingVanderbilt University Medical Center (VUMC), in collaboration with Mayo Clinic and leading…

ByByAnuja SinghJun 4, 2025
How Carterra, Pfizer, and GSK Are Scaling AI…

Key Highlights AI at the Core of the Next Drug Discovery WaveCarterra Inc., a front-runner in high-throughput biology,…

ByByAnuja SinghJun 4, 2025
How Is Caltech’s AI Smart Bandage Set to…

Key Highlights Smart Bandage Breakthrough: A Strategic AI-Driven Platform from CaltechIn a landmark step toward intelligent wound management,…

ByByAnuja SinghJun 4, 2025
Can Bayer’s Partnership with Altis Labs’ AI Boost…

Altis’ IPRO-Δ AI model outperforms RECIST in predicting survival, signaling a major shift in oncology trial endpoint Altis-Bayer…

ByByAnuja SinghJun 4, 2025
Is IBM and Inclusive Brains’ AI-Quantum Fusion the…

Key Highlights Advancing Accessibility Through Multimodal AI and Brain-Machine InterfacesThe collaboration aims to improve the classification accuracy of…

ByByAnuja SinghJun 3, 2025
AI at the FDA: Will ‘Elsa’ Redefine How…

Key highlights Regulatory AI Disruption: Why the FDA’s ‘Elsa’ Tool Is a Gamechanger for Biopharma The U.S. Food…

ByByAnuja SinghJun 3, 2025

Latest Stories

Don’t miss our hot and upcoming stories
Can Catalio Capital’s $400 Million AI-Driven Life Sciences Fund Ignite a New Era of Biomedical Innovation Despite a Slow VC Market?

Key Takeaways Resilience in a Cooling VC ClimateCatalio Capital Management has successfully closed its fourth…

ByByAnuja SinghJul 2, 2025
Is Microsoft’s AI Diagnostic Orchestrator the Beginning of the End for Traditional Doctors — With 4X Higher Accuracy Shaking Up Global Healthcare?

Key Highlights Breakthrough in Diagnostic Accuracy with Microsoft’s AIMicrosoft announced its Diagnostic Orchestrator achieved 85.5%…

ByByAnuja SinghJul 2, 2025
Can Premier’s $12B AI-Driven IllumiCare Acquisition Transform Clinical Decision Support for 82,000 Providers in the Value-Based Care Race?

Key Takeaways Strategic Integration: Empowering AI at the Point of CarePremier’s move to buy IllumiCare…

ByByAnuja SinghJul 2, 2025
Is Portal Biotech’s $35M Series A Set to Redefine Proteomics With the World’s First AI-Powered Full-Length Single-Molecule Protein Sequencer?

Key Takeaways Transforming Protein Sequencing With AI and Nanopore InnovationPortal Biotech, a London-based pioneer in…

ByByAnuja SinghJul 1, 2025
Scroll to Top